Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.

CNS Spectr

1Psychiatry Research, The Zucker Hillside Hospital,North Shore-Long Island Jewish Health System,Glen Oaks,New York,USA.

Published: December 2014

Since currently available antipsychotic medications predominantly treat hallucinations, delusions, disorganized thoughts and behavior, and related agitation/aggression, attention has traditionally been focused on managing positive symptoms. However, prominent negative symptoms and clinically relevant cognitive impairment affect approximately 40% and 80% of people with schizophrenia, respectively. Moreover, negative and cognitive symptoms are closely related to functional outcomes, and contribute substantially to the overall illness burden. Therefore, approaches to describe, measure, and manage these symptom domains are relevant. This article summarizes the phenomenology, prevalence, assessment, and treatment of negative and cognitive symptoms in patients with schizophrenia, including pharmacologic and nonpharmacologic management strategies that can be used in clinical care now, as well as pharmacologic approaches that are being tested. Currently, no approved treatments targeting negative or cognitive symptomatology in schizophrenia are available. It is hoped that progress in the understanding of the neurobiology of these important symptom domains of schizophrenia will help develop effective treatment strategies in the future. However, until this goal is achieved, clinicians should avoid therapeutic nihilism. Rather, the severity and impact of negative and cognitive symptoms should be determined, quantified, and monitored. Further, psychosocial treatments have shown therapeutic benefits. Thus, cognitive behavioral therapy, cognitive remediation, social skills training, and computer-assisted training programs should be offered in conjunction with antipsychotic treatment. Several non-antipsychotic augmentation strategies can be tried off-label. Treatment plans that incorporate currently available management options for negative and cognitive symptomatology in patients with schizophrenia should be adapted over time and based on the individual's needs, with the aim to enhance overall outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1092852914000601DOI Listing

Publication Analysis

Top Keywords

negative cognitive
20
cognitive symptoms
12
cognitive
9
negative symptoms
8
symptom domains
8
patients schizophrenia
8
cognitive symptomatology
8
negative
7
symptoms
6
schizophrenia
6

Similar Publications

Objective: Posttraumatic stress symptoms (PTSS) and moral injury (MI) are possible negative outcomes of combat military service. While PTSS is known to be associated with impaired paternal parenting, no study has examined the association between MI and parenting. This study examined associations between military-related PTSS, MI, and multiple measures of parenting among veteran fathers.

View Article and Find Full Text PDF

Schizotypy is a multidimensional construct that is composed of positive, negative, and disorganized dimensions. Historically, disorganized schizotypy, which involves disruptions in thoughts, speech, behavior, and affect, has been relatively understudied and less clearly operationalized than the other dimensions. The present study employed experience sampling methodology to examine the associations of positive, negative, and disorganized schizotypy, as measured by the Multidimensional Schizotypy Scale, with daily life experiences.

View Article and Find Full Text PDF

Face stereotypes are prevalent, consequential, yet oftentimes inaccurate. How do false first impressions arise and persist despite counter-evidence? Building on the overgeneralization hypothesis, we propose a domain-general cognitive mechanism: insufficient statistical learning, or Insta-learn. This mechanism posits that humans are quick statistical learners but insufficient samplers.

View Article and Find Full Text PDF

Background: Non-motor symptoms, including depression, anxiety, sleep disturbances, pain and cognitive dysfunction, are a much more important predictor of quality of life than the severity of dystonia.

Objectives: To assess the effect of Botulinum toxin on non-motor symptoms and quality of life in patients with adult-onset idiopathic focal dystonia.

Methods: Patients aged > 18 years diagnosed with idiopathic focal dystonia were recruited in this longitudinal cohort study.

View Article and Find Full Text PDF

The Daily Process of Interpersonal Conflict and Mood among Chinese Adolescents: A Multilevel Moderated Mediation Analysis of Cognitive Appraisal, Social Support and Psychological Capital.

Res Child Adolesc Psychopathol

January 2025

School of Developmental Psychology, Faculty of Psychology, Beijing Normal University, 19 Xinjiekouwai Avenue, Haidian District, Beijing, 100875, China.

A growing body of literature has confirmed the within-person process from interpersonal conflict to adolescent mood on a day-to-day timescale. However, research on how, when and for whom adolescent interpersonal conflict relates to their daily mood is underdeveloped. This study examined whether interpersonal conflict is related to mood through threat appraisal and self-blaming attribution and whether these relationships would be moderated by daily social support and psychological capital.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!